A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas

Clinical trial NCT00878800 · COMPLETED

Trial details

NCT number: NCT00878800
Sponsor: Valerio Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Dose Escalation: Solid Tumors MTD: Soft Tissue Sarcomas

Start date: 2006-12-01
Primary completion: 2012-10-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.